RAGE Signaling in Melanoma Tumors

Despite recent progresses in its treatment, malignant cutaneous melanoma remains a cancer with very poor prognosis. Emerging evidences suggest that the receptor for advance glycation end products (RAGE) plays a key role in melanoma progression through its activation in both cancer and stromal cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Olaoba, Olamide T., Kadasah, Sultan, Vetter, Stefan W., Leclerc, Estelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730603/
https://www.ncbi.nlm.nih.gov/pubmed/33256110
http://dx.doi.org/10.3390/ijms21238989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730603/
https://www.ncbi.nlm.nih.gov/pubmed/33256110
http://dx.doi.org/10.3390/ijms21238989

Ejemplares similares